Attached files

file filename
EX-10.2 - EXHIBIT 10.2 - LHC Group, Incexhibit102.htm
EX-31.2 - EXHIBIT 31.2 - LHC Group, Inclhc-20150930exx312.htm
EX-31.1 - EXHIBIT 31.1 - LHC Group, Inclhc-20150930exx311.htm
EX-32.1 - EXHIBIT 32.1 - LHC Group, Inclhc-20150930exx321.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
 FORM 10-Q
 
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2015
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number: 001-33989
 
LHC GROUP, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
71-0918189
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
901 Hugh Wallis Road South
Lafayette, LA 70508
(Address of principal executive offices including zip code)
(337) 233-1307
(Registrant’s telephone number, including area code)

420 West Pinhook Road, Suite A
Lafayette, LA 70503
(Former name, former address and former fiscal year, if changed since last report)
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
  
¨
 
Accelerated filer
 
ý
 
 
 
 
Non-accelerated filer
  
¨  (Do not check if a smaller reporting company)
 
Smaller reporting company  
 
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  ý
Number of shares of common stock, par value $0.01, outstanding as of November 2, 2015: 17,970,294 shares.



LHC GROUP, INC.
INDEX
 
 
 
Page
Part I. Financial Information
 
Item 1.
 
Item 2.
Item 3.
35
Item 4.
Part II. Other Information
 
Item 1.
Item 1A.
Item 2.
Item 6.
37

2


PART I — FINANCIAL INFORMATION
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.
LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)
(Unaudited)
 
September 30, 
 2015
 
December 31, 
 2014
ASSETS
 
 
 
Current assets:
 
 
 
Cash
$
61,733

 
$
531

Receivables:
 
 
 
Patient accounts receivable, less allowance for uncollectible accounts of $25,931 and $18,582, respectively
107,139

 
97,498

Other receivables
1,245

 
1,334

Amounts due from governmental entities
961

 
1,164

Total receivables, net
109,345

 
99,996

Deferred income taxes
15,833

 
11,381

Prepaid income taxes
2,314

 
3,093

Prepaid expenses
10,038

 
8,724

Other current assets
6,119

 
3,777

Receivable due from insurance carrier
550

 
7,850

Total current assets
205,932

 
135,352

Property, building and equipment, net of accumulated depreciation of $43,642 and $44,683, respectively
38,255

 
34,787

Goodwill
242,062

 
240,019

Intangible assets, net of accumulated amortization of $7,964 and $6,560, respectively
80,731

 
79,685

Other assets
1,907

 
1,896

Total assets
$
568,887

 
$
491,739

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Current liabilities:
 
 
 
Accounts payable and other accrued liabilities
$
22,269

 
$
19,278

Salaries, wages, and benefits payable
35,447

 
22,466

Self-insurance reserve
9,692

 
6,559

Current portion of long-term debt
238

 
230

Amounts due to governmental entities
4,051

 
4,459

Legal settlement payable
550

 
7,850

Total current liabilities
72,247

 
60,842

Deferred income taxes
39,169

 
33,592

Income tax payable
3,415

 
3,415

Revolving credit facility
92,000

 
60,000

Long-term debt, less current portion
608

 
778

Total liabilities
207,439

 
158,627

Noncontrolling interest — redeemable
11,890

 
11,517

Stockholders’ equity:
 
 
 
LHC Group, Inc. stockholders’ equity:
 
 
 
Common stock — $0.01 par value; 40,000,000 shares authorized; 22,221,755 and 22,015,211 shares issued in 2015 and 2014, respectively
222

 
220

Treasury stock — 4,775,913 and 4,734,363 shares at cost, respectively
(37,109
)
 
(35,660
)
Additional paid-in capital
113,192

 
108,708

Retained earnings
269,971

 
245,371

Total LHC Group, Inc. stockholders’ equity
346,276

 
318,639

Noncontrolling interest — non-redeemable
3,282

 
2,956

Total equity
349,558

 
321,595

Total liabilities and equity
$
568,887

 
$
491,739

See accompanying notes to condensed consolidated financial statements.

3


LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in thousands, except share and per share data)
(Unaudited)
 
 
Three Months Ended  
 September 30,
 
Nine Months Ended 
 September 30,
 
2015
 
2014
 
2015
 
2014
Net service revenue
$
204,122

 
$
187,713

 
$
597,373

 
$
540,261

Cost of service revenue
120,873

 
113,122

 
351,938

 
321,983

Gross margin
83,249

 
74,591

 
245,435

 
218,278

Provision for bad debts
4,809

 
3,974

 
14,873

 
11,699

General and administrative expenses
60,748

 
58,197

 
180,416

 
172,499

Operating income
17,692

 
12,420

 
50,146

 
34,080

Interest expense
(434
)
 
(643
)
 
(1,533
)
 
(1,861
)
Income before income taxes and noncontrolling interest
17,258

 
11,777

 
48,613

 
32,219

Income tax expense
6,148

 
3,924

 
17,097

 
11,199

Net income
11,110

 
7,853

 
31,516

 
21,020

Less net income attributable to noncontrolling interests
2,265

 
1,679

 
6,916

 
4,717

Net income attributable to LHC Group, Inc.’s common stockholders
$
8,845

 
$
6,174

 
$
24,600

 
$
16,303

Earnings per share — basic:
 
 
 
 
 
 
 
Net income attributable to LHC Group, Inc.’s common stockholders
$
0.51

 
$
0.36

 
$
1.41

 
$
0.95

Earnings per share — diluted:
 
 
 
 
 
 
 
Net income attributable to LHC Group, Inc.'s common stockholders
$
0.50

 
$
0.36

 
$
1.40

 
$
0.94

Weighted average shares outstanding:
 
 
 
 
 
 
 
Basic
17,436,731

 
17,260,078

 
17,389,934

 
17,213,648

Diluted
17,610,953

 
17,356,916

 
17,526,687

 
17,289,554

 




See accompanying notes to the condensed consolidated financial statements.


4


LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
(Amounts in thousands, except share data)
(Unaudited)
 
 
Common Stock
 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Noncontrolling
Interest Non
Redeemable
 
Total
Equity
 
Issued
 
Treasury
 
 
Amount
 
Shares
 
Amount
 
Shares
 
 
Balance as of December 31, 2014
$
220

 
22,015,211

 
$
(35,660
)
 
(4,734,363
)
 
$
108,708

 
$
245,371

 
$
2,956

 
$
321,595

 
Net income

 

 

 

 

 
24,600

 
1,350

 
25,950

(1)
Noncontrolling interest

 

 

 

 

 

 
155

 
155

 
Purchase of noncontrolling interest

 

 

 

 
(275
)
 

 

 
(275
)
 
Noncontrolling interest distributions

 

 

 

 

 

 
(1,179
)
 
(1,179
)
 
Stock options exercised

 
9,500

 

 

 
145

 

 

 
145

 
Nonvested stock compensation

 

 

 

 
3,150

 

 

 
3,150

 
Issuance of vested stock

 
179,321

 

 

 

 

 

 

 
Treasury shares redeemed to pay income tax

 

 
(1,449
)
 
(41,550
)
 

 

 

 
(1,449
)
 
Excess tax benefits — vesting nonvested stock

 

 

 

 
897

 

 

 
897

 
Issuance of common stock under Employee Stock Purchase Plan
2

 
17,723

 

 

 
567

 

 

 
569

 
Balance as of September 30, 2015
$
222

 
22,221,755

 
$
(37,109
)
 
(4,775,913
)
 
$
113,192

 
$
269,971

 
$
3,282

 
$
349,558

 
 
(1)
Net income excludes net income attributable to noncontrolling interest-redeemable of $5.6 million during the nine months ended September 30, 2015. Noncontrolling interest-redeemable is reflected outside of permanent equity on the condensed consolidated balance sheets. See Note 9 of the Notes to Condensed Consolidated Financial Statements.


See accompanying notes to condensed consolidated financial statements.

5



LHC GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
 
 
Nine Months Ended 
 September 30,
 
2015
 
2014
Operating activities:
 
 
 
Net income
$
31,516

 
$
21,020

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization expense
8,685

 
6,874

Provision for bad debts
14,873

 
11,699

Stock-based compensation expense
3,150

 
3,086

Deferred income taxes
1,125

 
522

Impairment of intangibles
248

 

Loss on disposal of assets
680

 
21

Changes in operating assets and liabilities, net of acquisitions:
 
 
 
Receivables
(24,643
)
 
(12,868
)
Prepaid expenses and other assets
(3,660
)
 
280

Prepaid income taxes
779

 
4,005

Accounts payable and accrued expenses
19,071

 
(1,283
)
Net amounts due to/from governmental entities
(205
)
 
95

Net cash provided by operating activities
51,619

 
33,451

Investing activities:
 
 
 
Purchases of property, building and equipment
(11,401
)
 
(4,872
)
Cash paid for acquisitions, primarily goodwill and intangible assets
(4,359
)
 
(73,194
)
Net cash used in investing activities
(15,760
)
 
(78,066
)
Financing activities:
 
 
 
Proceeds from line of credit
64,000

 
72,000

Payments on line of credit
(32,000
)
 
(30,000
)
Proceeds from employee stock purchase plan
569

 
575

Payments on debt
(172
)
 
(147
)
Noncontrolling interest distributions
(6,372
)
 
(5,086
)
Payment of deferred financing fees

 
(900
)
Excess tax benefits from vesting of stock awards
897

 
124

Redemption of treasury shares
(1,449
)
 
(923
)
Purchase of additional controlling interest
(275
)
 
(359
)
Proceeds from exercise of stock options
145

 

Sale of noncontrolling interest

 
193

Net cash provided by financing activities
25,343

 
35,477

Change in cash
61,202

 
(9,138
)
Cash at beginning of period
531

 
14,014

Cash at end of period
$
61,733

 
$
4,876

Supplemental disclosures of cash flow information:
 
 
 
Interest paid
$
1,227

 
$
1,827

Income taxes paid
$
14,242

 
$
6,946

See accompanying notes to condensed consolidated financial statements.


6


LHC GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Organization
LHC Group, Inc. (the “Company”) is a health care provider specializing in the post-acute continuum of care primarily for Medicare beneficiaries. The Company provides home health services, hospice services, community-based services, and facility-based services, the latter primarily through long-term acute care hospitals (“LTACHs”). As of September 30, 2015, the Company, through its wholly-owned and majority-owned subsidiaries, equity joint ventures and controlled affiliates, operated 342 service providers in 28 states within the continental United States.
Unaudited Interim Financial Information
The condensed consolidated balance sheets as of September 30, 2015 and December 31, 2014, and the related condensed consolidated statements of income for the three and nine months ended September 30, 2015 and 2014, condensed consolidated statement of changes in equity for the nine months ended September 30, 2015, condensed consolidated statements of cash flows for the nine months ended September 30, 2015 and 2014 and related notes (collectively, these financial statements and the related notes are referred to herein as the “interim financial information”) have been prepared by the Company. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been included. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted from the interim financial information presented. This report should be read in conjunction with the Company’s consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 as filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2015, which includes information and disclosures not included herein.
2. Significant Accounting Policies
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenue and expenses during the reporting period. Actual results could differ from those estimates.
Critical Accounting Policies
The Company’s most critical accounting policies relate to the principles of consolidation, revenue recognition and accounts receivable and allowances for uncollectible accounts.
Principles of Consolidation
The interim financial information includes all subsidiaries and entities controlled by the Company. Control is defined by the Company as ownership of a majority of the voting interest of an entity. The interim financial information includes entities in which the Company receives a majority of the entities’ expected residual returns and absorbs a majority of the entities’ expected losses. Third party equity interests in the consolidated joint ventures are reflected as noncontrolling interests in the Company’s interim financial information.






7


The following table summarizes the percentage of net service revenue earned by type of ownership or relationship the Company had with the operating entity:
 
 
Three Months Ended  
 September 30,
 
Nine Months Ended  
 September 30,
Type of ownership
 
2015
 
2014
 
2015
 
2014
Wholly-owned subsidiaries
 
54.5
%
 
54.5
%
 
54.5
%
 
52.9
%
Equity joint ventures
 
43.6

 
42.9

 
43.5

 
44.5

License leasing arrangements
 
1.0

 
1.8

 
1.1

 
1.8

Management services
 
0.9

 
0.8

 
0.9

 
0.8

 
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
All significant intercompany accounts and transactions have been eliminated in the Company’s accompanying interim financial information. Business combinations accounted for under the acquisition method have been included in the interim financial information from the respective dates of acquisition.
The following describes the Company’s consolidation policy with respect to its various ventures excluding wholly-owned subsidiaries:
Equity Joint Ventures
The members of the Company’s equity joint ventures participate in profits and losses in proportion to their equity interests. The Company consolidates these entities as the Company has voting control over the entities.
License Leasing Arrangements
The Company, through wholly-owned subsidiaries, leases home health licenses necessary to operate certain of its home nursing and hospice agencies. The Company owns 100% of the equity of these entities and consolidates them based on such ownership.
Management Services
The Company has various management services agreements under which the Company manages certain operations of agencies and facilities. The Company does not consolidate these agencies or facilities because the Company does not have an ownership interest in, and does not have an obligation to absorb losses of, the entities that own the agencies and facilities or the right to receive the benefits from those entities.
Revenue Recognition
The Company reports net service revenue at the estimated net realizable amount due from Medicare, Medicaid and other commercial or managed care insurance programs for services rendered. The Company assesses the patient's ability to pay for their healthcare services at the time of patient admission based on the Company's verification of the patient's insurance coverage under the Medicare, Medicaid, and other commercial or managed care insurance program. All such payors contribute to the net service revenue of the Company’s home health services, hospice services, community-based services, and facility-based services.
The following table sets forth the percentage of net service revenue earned by category of payor for the three and nine months ended September 30, 2015 and 2014:
 
 
 
Three Months Ended  
 September 30,
 
Nine Months Ended  
 September 30,
Payor
 
2015
 
2014
 
2015
 
2014
Medicare
 
74.0
%
 
75.2
%
 
74.2
%
 
76.3
%
Medicaid
 
1.5

 
1.7

 
1.5

 
1.4

Other
 
24.5

 
23.1

 
24.3

 
22.3

 
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%

8


The following table sets forth the percentage of net service revenue contributed from each reporting segment for the three and nine months ended September 30, 2015 and 2014:
 
 
 
Three Months Ended  
 September 30,
 
Nine Months Ended  
 June 30,
Reporting segment
 
2015
 
2014
 
2015
 
2014
Home health services
 
76.0
%
 
76.5
%
 
76.2
%
 
77.2
%
Hospice services
 
9.4

 
9.1

 
9.1

 
9.1

Community-based services
 
5.2

 
4.8

 
5.1

 
3.4

Facility-based services
 
9.4

 
9.6

 
9.6

 
10.3

 
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Medicare
Home Health Services
The Company’s home nursing Medicare patients are classified into one of 153 home health resource groups prior to receiving services. Based on the patient’s home health resource group, the Company is entitled to receive a standard prospective Medicare payment for delivering care over a 60-day period referred to as an episode. The Company recognizes revenue based on the number of days elapsed during an episode of care within the reporting period.
Final payments from Medicare may reflect one of four retroactive adjustments to ensure the adequacy and effectiveness of the total reimbursement: (a) an outlier payment if the patient’s care was unusually costly; (b) a low utilization adjustment if the number of visits was fewer than five; (c) a partial payment if the patient transferred to another provider before completing the episode; or (d) a payment adjustment based upon the level of therapy services required. In calculating net service revenue, management estimates the impact of these payment adjustments based on historical experience and records this estimate as the services are rendered using the expected level of services that will be provided.
Hospice Services
The Company is paid by Medicare under a per diem payment system. The Company receives one of four predetermined daily or hourly rates based upon the level of care the Company furnished. The Company records net service revenue from hospice services based on the daily or hourly rate and recognizes revenue as hospice services are provided.
Hospice payments are subject to an inpatient cap and an overall Medicare payment cap. The inpatient cap relates to an individual program receiving more than 20% of its total Medicare reimbursement from inpatient care services and the overall Medicare payment cap relates to individual providers receiving reimbursements in excess of a “cap amount,” calculated by multiplying the number of beneficiaries during the period by a statutory amount that is indexed for inflation. The determination for each cap is made annually based on the 12-month period ending on October 31 of each year. The Company monitors its limits on a provider-by-provider basis and records an estimate of its liability for reimbursements received in excess of the cap amount. Beginning with the cap year October 1, 2014, CMS implemented a new process requiring hospice providers to self-report their cap liabilities and remit applicable payment by March 31 of the following year.
Facility-Based Services
The Company is reimbursed by Medicare for services provided under the LTACH prospective payment system. Each patient is assigned a long-term care diagnosis-related group. The Company is paid a predetermined fixed amount intended to reflect the average cost of treating a Medicare patient classified in that particular long-term care diagnosis-related group. For selected patients, the amount may be further adjusted based on length of stay and facility-specific costs, as well as in instances where a patient is discharged and subsequently re-admitted, among other factors. The Company calculates the adjustment based on a historical average of these types of adjustments for claims paid. Similar to other Medicare prospective payment systems, the rate is also adjusted for geographic wage differences. Revenue is recognized for the Company’s LTACHs as services are provided.


9


Medicaid, Managed Care and Other Payors
The Company’s Medicaid reimbursement is based on a predetermined fee schedule applied to each service provided. Therefore, revenue is recognized for Medicaid services as services are provided based on this fee schedule. The Company’s managed care and other payors reimburse the Company based upon a predetermined fee schedule or an episodic basis, depending on the terms of the applicable contract. Accordingly, the Company recognizes revenue from managed care and other payors in the same manner as the Company recognizes revenue from Medicare or Medicaid.
Accounts Receivable and Allowances for Uncollectible Accounts
The Company reports accounts receivable net of estimated allowances for uncollectible accounts and adjustments. Accounts receivable are uncollateralized and primarily consist of amounts due from Medicare, other third-party payors and patients. To provide for accounts receivable that could become uncollectible in the future, the Company establishes an allowance for uncollectible accounts to reduce the carrying amount of such receivables to their estimated net realizable value. The credit risk for other concentrations of receivables is limited due to the significance of Medicare as the primary payor. The Company believes the credit risk associated with its Medicare accounts, which have historically exceeded 55% of its patient accounts receivable, is limited due to (i) the historical collection rate from Medicare and (ii) the fact that Medicare is a U.S. government payor. The Company does not believe that there are any other concentrations of receivables from any particular payor that would subject it to any significant credit risk in the collection of accounts receivable.
The provision for bad debts is based upon the Company’s assessment of historical and expected net collections, business and economic conditions and trends in government reimbursement. Uncollectible accounts are written off when the Company has determined the account will not be collected.
A portion of the estimated Medicare prospective payment system reimbursement from each submitted home nursing episode is received in the form of a request for anticipated payment (“RAP”). The Company submits a RAP for 60% of the estimated reimbursement for the initial episode at the start of care. The full amount of the episode is billed after the episode has been completed. The RAP received for that particular episode is deducted from the final payment. If a final bill is not submitted within the greater of 120 days from the start of the episode, or 60 days from the date the RAP was paid, any RAP received for that episode will be recouped by Medicare from any other Medicare claims in process for that particular provider. The RAP and final claim must then be resubmitted. For subsequent episodes of care contiguous with the first episode for a particular patient, the Company submits a RAP for 50% instead of 60% of the estimated reimbursement.
The Company’s services to the Medicare population are paid at prospectively set amounts that can be determined at the time services are rendered. The Company’s Medicaid reimbursement is based on a predetermined fee schedule applied to each individual service it provides. The Company’s managed care contracts and contracts with other payors provide for payments based upon a predetermined fee schedule or an episodic basis, depending on the terms of the applicable contract. Because of its payor mix, the Company is able to calculate its actual amount due at the patient level and adjust the gross charges down to the actual amount at the time of billing. This negates the need to record an estimated contractual allowance when reporting net service revenue for each reporting period.
Other Significant Accounting Policies
Earnings per Share
Basic per share information is computed by dividing the relevant amounts from the condensed consolidated statements of income by the weighted-average number of shares outstanding during the period, under the treasury stock method. Diluted per share information is also computed using the treasury stock method, by dividing the relevant amounts from the condensed consolidated statements of income by the weighted-average number of shares outstanding plus potentially dilutive shares.






10


The following table sets forth shares used in the computation of basic and diluted per share information:
 
 
Three Months Ended  
 September 30,
 
Nine Months Ended  
 September 30,
 
2015
 
2014
 
2015
 
2014
Weighted average number of shares outstanding for basic per share calculation
17,436,731

 
17,260,078

 
17,389,934

 
17,213,648

Effect of dilutive potential shares:
 
 
 
 
 
 
 
Options
2,227

 
4,367

 
4,070

 
4,151

Nonvested stock
171,995

 
92,471

 
132,683

 
71,755

Adjusted weighted average shares for diluted per share calculation
17,610,953

 
17,356,916

 
17,526,687

 
17,289,554

Anti-dilutive shares
8,000

 
3,500

 
182,185

 
173,360

Recently Issued Accounting Pronouncements
On May 28, 2014, the FASB issued ASU No. 2014-9, Revenue from Contracts with Customers, ("ASU 2014-9") which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-9 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for the Company on January 1, 2018. Early adoption is permitted to the original effective date of January 1, 2017. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is evaluating the effect that ASU 2014-9 will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.
3. Acquisitions and Disposals
The Company acquired the majority-ownership of four home health agencies, one hospice agency, and one community-based services agency during the nine months ended September 30, 2015. The total aggregate purchase prices for the Company’s acquisitions were $4.2 million, of which $3.9 million was paid in cash. The purchase prices are determined based on the Company’s analysis of comparable acquisitions and the target market’s potential future cash flows.
Acquired intangible assets consist of a Certificate of Need, Medicare licenses, Medicaid licenses, non-compete agreements, and trade names. The fair value of the acquired intangible assets was $2.0 million, which are preliminary pending the final valuation of those assets.
The Company's home health services segment, hospice services segment, and community-based services segment recognized goodwill of $0.6 million, $1.4 million, and $0.2 million, respectively. Goodwill generated from the acquisitions was recognized based on the expected contribution of the acquisitions to the overall corporate strategy. The Company expects its portion of goodwill to be fully tax deductible. The acquisitions were accounted for under the acquisition method of accounting, and, accordingly, the accompanying interim financial information includes the results of operations of the acquired entities from the dates of acquisition.

 








11




4. Goodwill and Intangibles
The changes in recorded goodwill by reporting unit for the nine months ended September 30, 2015 were as follows (amounts in thousands):
 
 
Home health
reporting unit
 
Hospice
reporting unit
 
Community-based
reporting unit
 
Facility-based
reporting unit
 
Total
Balance as of December 31, 2014
$
196,296

 
$
14,793

 
$
17,339

 
$
11,591

 
$
240,019

Goodwill from acquisitions
560

 
1,426

 
204

 

 
2,190

Goodwill related to noncontrolling interests
14

 

 
22

 

 
36

Goodwill related to disposal
(156
)
 

 
(27
)
 

 
(183
)
Balance as of September 30, 2015
$
196,714

 
$
16,219

 
$
17,538

 
$
11,591

 
$
242,062

Intangible assets consisted of the following as of September 30, 2015 and December 31, 2014 (amounts in thousands):
 
 
September 30, 2015
 
Remaining useful life
 
Gross
carrying
amount
 
Accumulated
amortization
 
Net
carrying
amount
Indefinite-lived assets:
 
 
 
 
 
 
 
Trade names
Indefinite
 
$
55,243

 
$

 
$
55,243

Certificates of need/licenses
Indefinite
 
20,349

 

 
20,349

Indefinite-lived balance at end of period
 
 
$
75,592

 
$

 
$
75,592

Definite-lived assets:
 
 
 
 
 
 
 
Trade names
2 years — 5 years
 
$
8,645

 
$
(4,002
)
 
$
4,643

Non-compete agreements
7 months — 3 years
 
4,458

 
(3,962
)
 
496

Definite-lived balance at end of period
 
 
$
13,103

 
$
(7,964
)
 
$
5,139

Balance as of September 30, 2015
 
 
$
88,695

 
$
(7,964
)
 
$
80,731

 
 
December 31, 2014
 
Remaining useful life

 
Gross
carrying
amount
 
Accumulated
amortization
 
Net
carrying
amount
Indefinite-lived assets:
 
 
 
 
 
 
 
Trade names
Indefinite
 
$
54,732

 
$

 
$
54,732

Certificates of need/licenses
Indefinite
 
19,058

 

 
19,058

Indefinite-lived balance at end of period
 
 
$
73,790

 
$

 
$
73,790

Definite-lived assets:
 
 
 
 
 
 
 
Trade names
2 months — 5 years
 
$
8,230

 
$
(2,797
)
 
$
5,433

Non-compete agreements
3 months — 2 years
 
4,225

 
(3,763
)
 
462

Definite-lived balance at end of period
 
 
$
12,455

 
$
(6,560
)
 
$
5,895

Balance as of December 31, 2014
 
 
$
86,245

 
$
(6,560
)
 
$
79,685


12


Intangible assets of $66.9 million, net of accumulated amortization, were related to the home health services segment, $5.6 million were related to the hospice services segment, $7.3 million were related to the community-based services segment and $0.9 million were related to the facility-based services segment as of September 30, 2015.

5. Debt
Credit Facility
On June 18, 2014, the Company entered into a Credit Agreement (the “Credit Agreement”) with Capital One, National Association, which provides a senior, secured revolving line of credit commitment with a maximum principal borrowing limit of $225.0 million and a letter of credit sub-limit equal to $15.0 million. The Credit Agreement replaces the Third Amended and Restated Credit Agreement with Capital One, National Association, dated August 31, 2012. The expiration date of the Credit Agreement is June 18, 2019. Revolving loans under the Credit Agreement bear interest at either a (1) Base Rate, which is defined as a fluctuating rate per annum equal to the highest of (a) the Federal Funds Rate in effect on such day plus 0.5% (b) the Prime Rate in effect on such day and (c) the Eurodollar Rate for a one month interest period on such day plus 1.0%, plus a margin ranging from 0.75% to 1.5% per annum or (2) Eurodollar rate plus a margin ranging from 1.75% to 2.5% per annum. Swing line loans bear interest at the Base Rate. The Company is limited to 15 Eurodollar borrowings outstanding at the same time. The Company is required to pay a commitment fee for the unused commitments at rates ranging from 0.225% to 0.375% per annum depending upon the Company’s consolidated Leverage Ratio, as defined in the Credit Agreement. The Base Rate at September 30, 2015 was 4.00% and the Eurodollar rate was 1.95%. As of September 30, 2015, the interest rate on outstanding borrowings was 3.40%.
As of September 30, 2015 and December 31, 2014, respectively, the Company had $92.0 million and $60.0 million drawn and letters of credit totaling $7.1 million outstanding under its credit facilities with Capital One, National Association.
As of September 30, 2015, the Company had $125.9 million available for borrowing under the Credit Agreement with Capital One, National Association.

6. Income Taxes
As of September 30, 2015, an unrecognized tax benefit of $3.4 million was recorded in income tax payable, which, if recognized, would decrease the Company’s effective tax rate. All of the Company’s unrecognized tax benefit is due to the settlement with the United States of America, which was announced September 30, 2011. On July 30, 2014, the Internal Revenue Service (“IRS”) issued a notice of proposed adjustment asserting that a portion of the original tax deduction claimed by the Company associated with the settlement with the United States of America should be disallowed. The Company is currently appealing this proposed adjustment with IRS Appeals. The Company intends to vigorously defend its original position of the deductibility of the full settlement amount on its 2011 tax return.
7. Stockholder’s Equity
Equity Based Awards
The 2010 Long Term Incentive Plan (the “2010 Incentive Plan”) is administered by the Compensation Committee of the Company’s Board of Directors. A total of 1,500,000 shares of the Company’s common stock are reserved and 491,037 shares are currently available for issuance pursuant to awards granted under the 2010 Incentive Plan. A variety of discretionary awards for employees, officers, directors and consultants are authorized under the 2010 Incentive Plan, including incentive or non-qualified statutory stock options and nonvested stock. All awards must be evidenced by a written award certificate which will include the provisions specified by the Compensation Committee of the Board of Directors. The Compensation Committee determines the exercise price for non-statutory stock options. The exercise price for any option cannot be less than the fair market value of the Company’s common stock as of the date of grant.
Share Based Compensation
Nonvested Stock
During the nine months ended September 30, 2015, the Company’s independent directors were granted 16,200 nonvested shares of common stock under the 2005 Director Compensation Plan. The shares were drawn from the 1,500,000 shares of

13


common stock reserved for issuance under the 2010 Incentive Plan. The shares vest 100% on the one year anniversary date. During the nine months ended September 30, 2015, employees were granted 182,865 nonvested shares of common stock pursuant to the 2010 Incentive Plan. The shares vest over a five year period, conditioned on continued employment. The fair value of nonvested shares of common stock is determined based on the closing trading price of the Company’s common stock on the grant date. The weighted average grant date fair value of nonvested shares of common stock granted during the nine months ended September 30, 2015 was $34.06.
The following table represents the nonvested stock activity for the nine months ended September 30, 2015:
 
 
Number of
shares
 
Weighted
average grant
date fair value
Nonvested shares outstanding as of December 31, 2014
524,287

 
$
22.56

Granted
199,065

 
$
34.06

Vested
(176,195
)
 
$
23.23

Forfeited
(15,880
)
 
$
22.44

Nonvested shares outstanding as of September 30, 2015
531,277

 
$
26.65

During the nine months ended September 30, 2015, an independent director of the Company received a share based award, which will be settled in cash at March 1, 2016. The amount of such cash payment will equal the fair market value of 1,800 shares on the settlement date.
As of September 30, 2015, there was $10.5 million of total unrecognized compensation cost related to nonvested shares of common stock granted. That cost is expected to be recognized over the weighted average period of 3.12 years. The total fair value of shares of common stock vested during the nine months ended September 30, 2015 and 2014 was $4.1 million and $3.9 million, respectively. The Company records compensation expense related to nonvested stock awards at the grant date for shares of common stock that are awarded fully vested, and over the vesting term on a straight line basis for shares of common stock that vest over time. The Company recorded $3.2 million and $3.1 million of compensation expense related to nonvested stock grants in the nine months ended September 30, 2015 and 2014, respectively.
Employee Stock Purchase Plan
In 2006, the Company adopted the Employee Stock Purchase Plan whereby eligible employees may purchase the Company’s common stock at 95% of the market price on the last day of the calendar quarter. There were 250,000 shares of common stock initially reserved for the plan. In 2013, the Company adopted the Amended and Restated Employee Stock Purchase Plan, which reserved an additional 250,000 shares of common stock to the plan.
The table below details the shares of common stock issued during 2015:
 
 
Number of
shares
 
Per share
price
Shares available as of December 31, 2014
236,483

 
 
Shares issued during three months ended March 31, 2015
7,068

 
$
29.62

Shares issued during three months ended June 30, 2015
5,702

 
$
31.38

Shares issued during three months ended September 30, 2015
4,953

 
$
36.34

Shares available as of September 30, 2015
218,760

 
 
Stock Options
During the nine months ended September 30, 2015, 9,500 options were exercised at a weighted average exercise price of $15.21. No options were granted or forfeited. As of September 30, 2015, 5,500 options are outstanding with an exercise price of $19.75. These options expire on June 14, 2016.

14


Treasury Stock
In conjunction with the vesting of the nonvested shares of common stock, recipients incur personal income tax obligations. The Company allows the recipients to turn in shares of common stock to satisfy minimum tax obligations. During the nine months ended September 30, 2015, the Company redeemed 41,550 shares of common stock valued at $1.4 million, related to these tax obligations.
8. Commitments and Contingencies
Contingencies
The Company is involved in various legal proceedings arising in the ordinary course of business. Although the results of litigation cannot be predicted with certainty, management believes the outcome of pending litigation will not have a material adverse effect, after considering the effect of the Company’s insurance coverage, on the Company’s interim financial information.
On June 13, 2012, a putative shareholder securities class action was filed against the Company and its Chairman and Chief Executive Officer in the United States District Court for the Western District of Louisiana, styled City of Omaha Police & Fire Retirement System v. LHC Group, Inc., et al., Case No. 6:12-cv-1609-JTT-CMH. The action was filed on behalf of LHC shareholders who purchased shares of the Company’s common stock between July 30, 2008 and October 26, 2011, alleging violations of Sections 10(b), 20(a) and 20A of the Securities Exchange Act of 1934, as amended. On June 16, 2014, following mediation, the parties entered into a Stipulation of Settlement. On August 5, 2014, the District Court entered an Order Preliminarily Approving Settlement and Providing for Notice. On March 3, 2015, the District Court entered its Judgments adopting the Report and Recommendation previously issued and dismissing the action with prejudice. The time for appeal has passed and no appeals were filed. This matter is now concluded. The Company's insurance carrier has funded the entire $7.9 million settlement amount.
On October 18, 2013, a derivative complaint was filed by a purported Company shareholder against certain of the Company’s current and former executive officers, employees and members of its Board of Directors in the United States District Court for the Western District of Louisiana, styled Plummer v. Myers, et al., Case No. 6:13-cv-2899-JTT-CMH. The action was brought derivatively on behalf of the Company, which is also named as a nominal defendant. Plaintiff generally alleges that the individual defendants breached their fiduciary duties owed to the Company. The complaint also alleges claims for insider selling and unjust enrichment against the Company’s Chairman and Chief Executive Officer and the Company’s former President and Chief Operating Officer.
On December 30, 2013, a related derivative complaint was filed by a purported Company shareholder against certain of the Company’s current and former executive officers, employees and members of its Board of Directors in the United States District Court of the Western District of Louisiana, styled McCormack v. Myers, et al., Case No. 6:13-cv-3301-JTT-CMH. The action was brought derivatively on the Company’s behalf and the Company was also named as a nominal defendant. Plaintiff generally alleges that the individual defendants breached their fiduciary duties owed to the Company and wasted corporate assets. Plaintiff also alleges that the Company’s Chairman and Chief Executive Officer caused false and misleading statements to be issued in violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder and that the Company’s Directors are control persons under Section 20(a) of the Exchange Act. The complaint also alleges claims for insider selling, misappropriation of information and unjust enrichment against the Company’s Chairman and Chief Executive Officer and the Company’s former President and Chief Operating Officer.
The Company believes the claims made in the Plummer and McCormack cases are without merit.
On March 25, 2014, the McCormack derivative action was consolidated with the Plummer derivative action described above and stayed. On October 7, 2015, the parties entered into a Stipulation of Settlement. On October 19, 2015, Plaintiffs filed an Unopposed Motion for Preliminary Approval of Proposed Derivative Settlement. On October 26, 2015, the District Court entered an Order Preliminarily Approving Settlement in the amount of $0.6 million, and set a final fairness hearing for January 20, 2016. If the settlement is approved by the District Court, the Company' s insurance carrier will fund the settlement amount. The Company's balance sheet reflects the entire settlement in current assets as a receivable due from insurance carrier and correspondingly reflects the entire settlement in current liabilities as a legal settlement payable.
Except as discussed above, the Company is not aware of any pending or threatened investigations involving allegations of potential wrongdoing.

15


Any negative findings in the above described lawsuits could result in substantial financial penalties or awards against the Company. At this time, the Company cannot predict the ultimate outcome of these matters or the potential range of damages, if any.
Joint Venture Buy/Sell Provisions
Most of the Company’s joint ventures include a buy/sell option that grants to the Company and its joint venture partners the right to require the other joint venture party to either purchase all of the exercising member’s membership interests or sell to the exercising member all of the non-exercising member’s membership interest, at the non-exercising member’s option, within 30 days of the receipt of notice of the exercise of the buy/sell option. In some instances, the purchase price is based on a multiple of the historical or future earnings before income taxes and depreciation and amortization of the equity joint venture at the time the buy/sell option is exercised. In other instances, the buy/sell purchase price will be negotiated by the partners and subject to a fair market valuation process. The Company has not received notice from any joint venture partners of their intent to exercise the terms of the buy/sell agreement nor has the Company notified any joint venture partners of its intent to exercise the terms of the buy/sell agreement.
Compliance
The laws and regulations governing the Company’s operations, along with the terms of participation in various government programs, regulate how the Company does business, the services offered and its interactions with patients and the public. These laws and regulations, and their interpretations, are subject to frequent change. Changes in existing laws or regulations, or their interpretations, or the enactment of new laws or regulations could materially and adversely affect the Company’s operations and financial condition.
The Company is subject to various routine and non-routine governmental reviews, audits and investigations. In recent years, federal and state civil and criminal enforcement agencies have heightened and coordinated their oversight efforts related to the health care industry, including referral practices, cost reporting, billing practices, joint ventures and other financial relationships among health care providers. Violation of the laws governing the Company’s operations, or changes in the interpretation of those laws, could result in the imposition of fines, civil or criminal penalties, and/or termination of the Company’s rights to participate in federal and state-sponsored programs and suspension or revocation of the Company’s licenses. The Company believes that it is in material compliance with all applicable laws and regulations.
9. Noncontrolling Interest
Noncontrolling Interest-Redeemable
A majority of the Company’s equity joint venture agreements include a provision that requires the Company to purchase the noncontrolling partner’s interest upon the occurrence of certain triggering events, such as death or bankruptcy of the partner or the partner’s exclusion from the Medicare or Medicaid programs. These triggering events and the related repurchase provisions are specific to each individual equity joint venture; if the repurchase provision is triggered in any one equity joint venture, the remaining equity joint ventures would not be impacted. Upon the occurrence of a triggering event, the Company would be required to purchase the noncontrolling partner’s interest at either the fair value or the book value at the time of purchase, as stated in the applicable joint venture agreement. Historically, no triggering event has occurred, and the Company believes the likelihood of a triggering event occurring is remote. The Company has never been required to purchase the noncontrolling interest of any of its equity joint venture partners. According to authoritative guidance, redeemable noncontrolling interests must be reported outside of permanent equity on the consolidated balance sheet in instances where there is a repurchase provision with a triggering event that is outside the control of the Company.
The following table summarizes the activity of noncontrolling interest-redeemable for the nine months ended September 30, 2015 (amounts in thousands):
 
Balance as of December 31, 2014
$
11,517

Net income attributable to noncontrolling interest-redeemable
5,566

Noncontrolling interest-redeemable distributions
(5,193
)
Balance as of September 30, 2015
$
11,890



16


10. Allowance for Uncollectible Accounts
The following table summarizes the activity in the allowance for uncollectible accounts for the nine months ended September 30, 2015 (amounts in thousands):
 
Balance as of December 31, 2014
$
18,582

Additions
14,873

Deductions
(7,524
)
Balance as of September 30, 2015
$
25,931

11. Fair Value of Financial Instruments
The carrying amounts of the Company’s cash, receivables, accounts payable and accrued liabilities approximate their fair values. The estimated fair value of intangible assets acquired was calculated using level 3 inputs based on the present value of anticipated future benefits. For the nine months ended September 30, 2015, the carrying value of the Company’s long-term debt approximates fair value as the interest rates approximates current rates.
12. Segment Information
The Company’s reportable segments consist of home health services, hospice services, community-based services, and facility-based services. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.
During the first quarter of 2015, the Company had a change in the composition of segments due to the community-based services meeting the criteria of qualitative thresholds established by ASC 280, Segment Reporting. Prior-period segment data has been restated to reflect the newly reportable segment. Community-based services were previously included in home-based services.
The following tables summarize the Company’s segment information for the three and nine months ended September 30, 2015 and 2014 (amounts in thousands):
 
 
Three Months Ended September 30, 2015
 
Home health services
 
Hospice services
 
Community-based services
 
Facility-
based
services
 
Total
Net service revenue
$
155,047

 
$
19,205

 
$
10,628

 
$
19,242

 
$
204,122

Cost of service revenue
90,013

 
11,691

 
7,276

 
11,893

 
120,873

Provision for bad debts
3,988

 
51

 
560

 
210

 
4,809

General and administrative expenses
47,666

 
5,398

 
2,091

 
5,593

 
60,748

Operating income
13,380

 
2,065

 
701

 
1,546

 
17,692

Interest expense
(343
)
 
(47
)
 
(5
)
 
(39
)
 
(434
)
Income before income taxes and noncontrolling interest
13,037

 
2,018

 
696

 
1,507

 
17,258

Income tax expense
4,602

 
713

 
297

 
536

 
6,148

Net income
8,435

 
1,305

 
399

 
971

 
11,110

Less net income (loss) attributable to noncontrolling interests
1,812

 
279

 
(29
)
 
203

 
2,265

Net income attributable to LHC Group, Inc.’s common stockholders
$
6,623

 
$
1,026

 
$
428

 
$
768

 
$
8,845

Total assets
$
449,038

 
$
41,694

 
$
33,070

 
$
45,085

 
$
568,887



17


 
Three Months Ended September 30, 2014
 
Home health services
 
Hospice
services
 
Community-based services
 
Facility-
based
services
 
Total
Net service revenue
$
143,675

 
$
17,071

 
$
8,973

 
$
17,994

 
$
187,713

Cost of service revenue
85,305

 
10,431

 
6,201

 
11,185

 
113,122

Provision for bad debts
3,644

 
269

 
109

 
(48
)
 
3,974

General and administrative expenses
46,501

 
4,721

 
1,900

 
5,075

 
58,197

Operating income
8,225

 
1,650

 
763

 
1,782

 
12,420

Interest expense
(510
)
 
(64
)
 
(5
)
 
(64
)
 
(643
)
Income before income taxes and noncontrolling interest
7,715

 
1,586

 
758

 
1,718

 
11,777

Income tax expense
3,005

 
521

 
29

 
369

 
3,924

Net income
4,710

 
1,065

 
729

 
1,349

 
7,853

Less net income (loss) attributable to noncontrolling interests
1,193

 
292

 
(8
)
 
202

 
1,679

Net income attributable to LHC Group, Inc.’s common stockholders
$
3,517

 
$
773

 
$
737

 
$
1,147

 
$
6,174

Total assets
$
390,536

 
$
34,622

 
$
34,244

 
$
36,229

 
$
495,631

 
Nine Months Ended September 30, 2015
 
Home health services
 
Hospice
services
 
Community-based services
 
Facility-
based
services
 
Total
Net service revenue
$
454,911

 
$
54,688

 
$
30,713

 
$
57,061

 
$
597,373

Cost of service revenue
262,604

 
32,634

 
21,632

 
35,068

 
351,938

Provision for bad debts
12,109

 
697

 
1,431

 
636

 
14,873

General and administrative expenses
141,696

 
15,397

 
6,376

 
16,947

 
180,416

Operating income
38,502

 
5,960

 
1,274

 
4,410

 
50,146

Interest expense
(1,211
)
 
(168
)
 
(17
)
 
(137
)
 
(1,533
)
Income before income taxes and noncontrolling interest
37,291

 
5,792

 
1,257

 
4,273

 
48,613

Income tax expense
12,999

 
2,056

 
557

 
1,485

 
17,097

Net income
24,292

 
3,736

 
700

 
2,788

 
31,516

Less net income (loss) attributable to noncontrolling interests
5,584

 
778

 
(101
)
 
655

 
6,916

Net income attributable to LHC Group, Inc.’s common stockholders
$
18,708

 
$
2,958

 
$
801

 
$
2,133

 
$
24,600

 

18


 
Nine Months Ended September 30, 2014
 
Home health services
 
Hospice
services
 
Community-based services
 
Facility-
based
services
 
Total
Net service revenue
$
417,329

 
$
49,361

 
$
18,259

 
$
55,312

 
$
540,261

Cost of service revenue
245,383

 
29,479

 
12,790

 
34,331

 
321,983

Provision for bad debts
9,968

 
467

 
507

 
757

 
11,699

General and administrative expenses
138,356

 
13,954

 
4,288

 
15,901

 
172,499

Operating income
23,622

 
5,461

 
674

 
4,323

 
34,080

Interest expense
(1,474
)
 
(186
)
 
(15
)
 
(186
)
 
(1,861
)
Income before income taxes and noncontrolling interest
22,148

 
5,275

 
659

 
4,137

 
32,219

Income tax expense
8,680

 
1,397

 
83

 
1,039

 
11,199

Net income
13,468

 
3,878

 
576

 
3,098

 
21,020

Less net income (loss) attributable to noncontrolling interests
3,341

 
828

 
(12
)
 
560

 
4,717

Net income attributable to LHC Group, Inc.’s common stockholders
$
10,127

 
$
3,050

 
$
588

 
$
2,538

 
$
16,303


During the nine months ended September 30, 2015, the Company's internal allocation methodology for recording income tax expense was changed to record each segment's respective tax expense on pretax net income at the Company's effective tax rate of 41.0%. Prior to this year, income tax expense was allocated to each segment based on their respective percentage of equity. There is no impact on the Company's consolidated income tax expense.

13.    Subsequent Event
  
On October 1, 2015, the Company closed on the acquisition of Halcyon Hospice, LLC and its operating subsidiaries, resulting in the purchase of 16 hospice agencies across three states for $58.5 million.
ITEM 2.     MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains certain statements and information that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements relate to future plans and strategies, anticipated events or trends, future financial performance and expectations and beliefs concerning matters that are not historical facts or that necessarily depend upon future events. The words “may,” “should,” “could,” “would,” “expect,” “plan,” “intend,” “anticipate,” “believe,” “estimate,” “project,” “predict,” “potential” and similar expressions are intended to identify forward-looking statements. Specifically, this report contains, among others, forward-looking statements about:
 
our expectations regarding financial condition or results of operations for periods after September 30, 2015;
our critical accounting policies;
our business strategies and our ability to grow our business;
our participation in the Medicare and Medicaid programs;
the impact of healthcare reform;
the reimbursement levels of Medicare and other third-party payors;
the prompt receipt of payments from Medicare and other third-party payors;
our future sources of and needs for liquidity and capital resources;
the effect of any changes in market rates on our operations and cash flows;

19


our ability to obtain financing;
our ability to make payments as they become due;
the outcomes of various routine and non-routine governmental reviews, audits and investigations;
our expansion strategy, the successful integration of recent acquisitions and, if necessary, the ability to relocate or restructure our current facilities;
the value of our proprietary technology;
the impact of legal proceedings;
our insurance coverage;
the costs of medical supplies;
our competitors and our competitive advantages;
our ability to attract and retain valuable employees;
the price of our stock;
our compliance with environmental, health and safety laws and regulations;
our compliance with health care laws and regulations;
our compliance with SEC laws and regulations and Sarbanes-Oxley requirements;
the impact of federal and state government regulation on our business; and
the impact of changes in our future interpretations of fraud, anti-kickback or other laws.
The forward-looking statements included in this report reflect our current views about future events and are based on assumptions and are subject to known and unknown risks and uncertainties. Many important factors could cause actual results or achievements to differ materially from any future results or achievements expressed in or implied by our forward-looking statements. Many of the factors that will determine future events or achievements are beyond our ability to control or predict. Important factors that could cause actual results or achievements to differ materially from the results or achievements reflected in our forward-looking statements include, among other things, the factors discussed in the Part II, Item 1A. “Risk Factors,” included in this report and in our other filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2014 (the “2014 Form 10-K”), as updated by our subsequent filings with the SEC. This report should be read in conjunction with the 2014 Form 10-K, and all of our other filings, including quarterly reports on Form 10-Q and current reports on Form 8-K made with the SEC through the date of this report.
You should read this report, the information incorporated by reference into this report and the documents filed as exhibits to this report completely and with the understanding that our actual future results or achievements may differ materially from what we expect or anticipate.
The forward-looking statements contained in this report reflect our views and assumptions only as of the date this report is filed with the SEC. Except as required by law, we assume no responsibility for updating any forward-looking statements.
We qualify all of our forward-looking statements by these cautionary statements. In addition, with respect to all of our forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Unless the context otherwise requires, “we,” “us,” “our,” and the “Company” refer to LHC Group, Inc. and its consolidated subsidiaries.
OVERVIEW
We provide quality cost-effective post-acute health care services to our patients. As of September 30, 2015, we have 342 service providers in 28 states: Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Nevada, North Carolina, Ohio, Oregon,

20


Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia and Wisconsin. Our services are classified into four segments: (1) home health services; (2) hospice services; (3) community-based services and (4) facility-based services offered through our long-term acute care hospitals (“LTACHs”).
Through our home health services segment, we offer a wide range of services, including skilled nursing, medically-oriented social services, and physical, occupational and speech therapy. As of September 30, 2015, we operate 278 home health services locations, of which 163 are wholly-owned, 109 are majority-owned through equity joint ventures, three are under license lease arrangements and the operations of the remaining three locations are only managed by us.
Through our hospice services segment, we offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. As of September 30, 2015, we operate 41 hospice locations, of which 28 are wholly-owned, 11 are majority-owned through equity joint ventures and two are under license lease arrangements.
Through our community-based services segment, our services are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. As of September 30, 2015, we operate 13 community-based services locations, of which 12 are wholly-owned and one is majority-owned through an equity joint venture.
We provide facility-based services principally through our LTACHs. As of September 30, 2015, we operate six LTACHs with eight locations, of which all but one are located within host hospitals. Of these facility-based services locations, three are wholly-owned and five are majority-owned through equity joint ventures. We also wholly-own and operate a family health center and a pharmacy.
The Joint Commission is a nationwide commission that establishes standards relating to the physical plant, administration, quality of patient care and operation of medical staffs of health care organizations. Currently, Joint Commission accreditation of home nursing and hospice agencies is voluntary. However, some managed care organizations use Joint Commission accreditation as a credentialing standard for regional and state contracts. As of September 30, 2015, the Joint Commission had accredited 243 of our 278 home health services locations and 32 of our 41 hospice agencies. Those not yet accredited are working towards achieving this accreditation. As we acquire companies, we apply for accreditation 12 to 18 months after completing the acquisition.
The percentage of net service revenue contributed from each reporting segment for the three and nine months ended September 30, 2015 and 2014 was as follows:
 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Type of segment
 
2015
 
2014
 
2015
 
2014
Home health services
 
76.0
%
 
76.5
%
 
76.2
%
 
77.2
%
Hospice services
 
9.4

 
9.1

 
9.1

 
9.1

Community-based services
 
5.2

 
4.8

 
5.1

 
3.4

Facility-based services
 
9.4

 
9.6

 
9.6

 
10.3

 
 
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%

Recent Developments
Home Health Services
When the Patient Protection and Affordable Care Act (“PPACA”) was enacted in 2010, it changed a number of Medicare payment rates, including the reinstatement of the 3% home health rural add-on, which began on April 1, 2010 (expiring January 1, 2016). Other changes from PPACA that took effect on or after January 1, 2011 are:
 
reducing the market basket adjustment to be determined by CMS for each of 2011, 2012 and 2013 by 1%,
instituting a full productivity adjustment beginning in 2015, and

21


rebasing of the base payment rate for Medicare beginning in 2014 and phasing in over a four year period.
On November 22, 2013, CMS issued a final rule (effective January 1, 2014) regarding payment rates for home health services provided during 2014, which includes the following elements:
decreased base payment rate by 1.05%, which is made up of a market basket increase of 2.3%, rebasing decrease of 2.75% and HH PPS Grouper refinements decrease of 0.6%,
reduced the average case-mix weight for 2014 from 1.3464 to 1.0000. To offset the effect of resetting the case mix average to 1.000, CMS upwardly-adjusted the national, standardized 60-day episode payment rate by the same factor that it used to decrease the case-mix weights from $2,137.73 in 2013 to $2,869.27 in 2014.
removed 170 diagnosis codes from assignment to diagnosis groups within HH PPS Grouper,
begin using ICD-10-CM codes within HH PPS Grouper. On April 1, 2014, the “Protecting Access to Medicare Act of 2014” HR4302 was signed, a provision of which delayed the conversion of ICD-10 by one year, to October 1, 2015, and
reduced rebasing amounts for 2014 through 2017 by an aggregate of $80.95, which is 3.5% of 2010 rates or 2.75% of 2013 rates.
On October 30, 2014, CMS issued a Final Rule (effective January 1, 2015) regarding payment rates for home health services provided during 2015. The net impact of all policies in the rule is a reduction in Medicare payments of 0.3%. CMS estimates that freestanding proprietary agencies will have a 0.9% reduction in Medicare reimbursement compared with 2014 levels. The final rule includes the following elements:
 
The national, standardized 60-day episode payment rate will increase from $2,869.27 in 2014 to $2,961.38 in 2015. This is a net 3.2% increase in standardized rate, due to application of (1) a wage index budget neutrality factor (+.24%) and (2) a case mix budget neutrality factor (+ 3.66%) to the 2014 standard rate which is offset by a recalibration of the case mix, then subtracting the rebasing adjustment of -$80.95 (2.82% of 2014 rates), then applying the net market basket adjustment of +2.1% (Market Basket=+2.6%, Productivity Adjustment=-0.5%).
The 2013 Office of Management and Budget ("OMB") core-based statistical area (“CBSA”) designations for calculating wage indexes will be adopted. The proposed rule would update the HHA wage index using a 50/50 blend of the existing CBSA designations and the new CBSA designations outlined in a February 28, 2013, Office of Management and Budget bulletin, respectively. Nationally, 37 counties will shift from urban to rural and 105 counties will shift from rural to urban.
The face-to-face narrative requirement was eliminated. CMS will only consider medical records from the patient’s certifying physician or discharging facility in determining initial eligibility for Medicare’s home health benefit. Physician claims for certification/re-certification of eligibility (not the face-to-face encounter visit) will be considered a non-covered service if the HHA claim was non-covered because the patient was ineligible for the home health benefit.
The scheduling and administration of therapy reassessments will be modified to every 30 calendar days as opposed to tracking and counting therapy visits, especially for multiple-discipline therapy episodes.
The 3% rural add-on will only apply to counties that are classified as rural under the 2013 CBSA designation. Nationally, 37 counties will shift from urban to rural and pick up the rural add-on, and 105 counties will shift from rural to urban and will lose the rural add-on, but may offset some of that loss by a positive increase in wage index.
CMS also made several minor policy changes, which will not affect reimbursement.
On April 14, 2015, legislation was passed which limits any increase in home health payments to 1% for fiscal year 2018, and extends the 3% rural home health safeguard for two years through December 31, 2017.
On October 30, 2015, CMS released a Final Rule (effective January 1, 2016) regarding payment rates for home health services provided during calendar year 2016. The national, standardized 60-day episode payment rate will increase to $2,965.12 in 2016. The rural rate will be $3,054.07. This is a net 0.01% increase in the national, standardized 60-day episode payment rate, due to application of (1) rebasing decrease of 2.75%, (2) case-mix adjustment decrease of 0.97%, (3) net market basket increase of 1.9%, (4) case-mix recalibration budget neutrality adjustment increase of 1.87%, and (5) wage index budget

22


neutrality adjustment increase of 0.11%. The home health market basket percentage increase for 2016 is 2.3% and the multifactor productivity adjustment is 0.4% for a net home health market based of 1.9%. CMS reduced its estimate of nominal case-mix growth between 2012 and 2014 from 3.41% to 2.88% (0.53%) and spread the adjustment over three years at 0.97% each year to account for nominal case-mix growth. The finalized payment policies result in a 1.4% reduction in Medicare payments for all home health agencies.
In addition, CMS finalized its proposal implement a Home Health Value-Based Purchasing ("HHVBP") program that is intended to incentivize the delivery of high-quality patient care. The HHVBP program would withhold 3% to 8% of Medicare payments, which would be redistributed to participating home health agencies depending on their performance relative to specified measures. The HHVBP would apply to all home health agencies in Arizona, Florida, Iowa, Massachusetts, Maryland, Nebraska, North Carolina, Tennessee, and Washington.
Hospice Services
On August 22, 2014, CMS released a Final Rule for hospice for fiscal year 2015, which increased Medicare reimbursement payments by 1.4% over fiscal year 2014. The 1.4% increase consists of a 2.9% inflationary market basket update offset by a 0.7% reduction related to the wage index changes and the sixth year of CMS's seven-year phase-out of its wage index budget neutrality adjustment factor, a 0.5% reduction for the productivity adjustment, and a 0.3% reduction to the market basket as defined by PPACA. The following table shows the hospice Medicare payment rates for fiscal year 2015, which began on October 1, 2014 and ended September 30, 2015:
Description
Rate per patient day
Routine Home Care
$
159.34

Continuous Home Care
$
929.91

Full Rate = 24 hours of care
 
$38.75 = hourly rate
 
Inpatient Respite Care
$
164.81

General Inpatient Care
$
708.77

On July 31, 2015, CMS released a Final Rule that would update the Medicare hospice payment rates and wage index for fiscal year 2016, which is estimated to be an increase in payment rates of 1.1%. Beginning January 1, 2016, CMS is finalizing its proposal for two routine home care rates, in a budget-neutral manner, to provide separate payment rates for the first 60 days of care and care beyond 60 days. In addition to the two routine home care rates, CMS is implementing a service intensity add-on payment that would help to promote and compensate for the provision of skilled visits at end of life. As finalized, fiscal year 2016 will be the seventh and final year of the Budget Neutrality Adjustment Factor for hospice. CMS is updating the aggregate hospice cap to $27,382.63 for the cap year ending October 31, 2015 and to $27,820.75 for the 2016 cap year. CMS is also changing the hospice inpatient and aggregate cap year to coincide with the fiscal year (October 1 to September 30) beginning October 1, 2017. The following table shows the hospice Medicare payment rates for fiscal year 2016, which began on October 1, 2015 and will end September 30, 2016:
Description
Rate per patient day
Routine Home Care (October 1, 2015 through December 31, 2015)
$
161.89

Routine Home Care days 1-60 (effective January 1, 2016)
$
186.84

Routine Home Care days 60+ (effective January 1, 2016)
$
146.83

Continuous Home Care
$
944.79

    Full Rate = 24 hours of care
 
    $39.37 = hourly rate
 
Inpatient Respite Care
$
167.45

General Inpatient Care
$
720.11

   
Community-Based Services

23


Community-based services are care services, which are primarily performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. Revenue is generated on an hourly basis and our current primary payors are TennCare Managed Care Organization and Medicaid. Approximately 82% of our net service revenue in this segment was generated in Tennessee.
Facility-Based Services
On December 26, 2013, President Obama signed into law the Bipartisan Budget Act of 2013 (Public Law 113-67). This new law prevents a scheduled payment reduction for physicians and other practitioners who treat Medicare patients from taking effect on January 1, 2014. Included in the legislation are the following changes to LTACH reimbursement:
 
Medicare discharges from LTACHs will continue to be paid at full LTACH PPS rates if:
the patient spent at least three days in a short-term care hospital (“STCH”) intensive care unit (“ICU”) during a STCH stay that immediately preceded the LTACH stay, or
the patient was on a ventilator for more than 96 hours in the LTACH (based on the MS-LTACH DRG assigned) and had a STCH stay immediately preceding the LTACH stay.
Also, the LTACH discharge cannot have a principal diagnosis that is psychiatric or rehabilitation. 
All other Medicare discharges from LTACHs will be paid at a new “site neutral” rate, which is the lesser of:
the IPPS comparable per diem amount determined using the formula in the short-stay outlier regulation at 42 C.F.R. § 412.529(d)(4) plus applicable outlier payments, or
100% of the estimated cost of the services involved.
The above new payment policy will not be effective until LTACH cost reporting periods beginning on or after October 1, 2015, and the site neutral payment rate will be phased-in over three years.
For cost reporting periods beginning on or after October 1, 2015, discharges paid at the site neutral payment rate or by a Medicare Advantage plan (Part C) will be excluded from the LTACH average length-of-stay (“ALOS”) calculation.
For cost reporting periods beginning in fiscal year 2016 and later, CMS will notify LTACHs of their “LTACH discharge payment percentage” (i.e., the number of discharges not paid at the site neutral payment rate divided by the total number of discharges).
For cost reporting periods beginning in fiscal year 2020 and later, LTACHs with less than 50% of their discharges paid at the full LTACH PPS rates will be switched to payment under the IPPS for all discharges in subsequent cost reporting periods. However, CMS will set up a process for LTACHs to seek reinstatement of LTACH PPS rates for applicable discharges.
MedPAC will study the impact of the above changes on quality of care, use of hospice and other post-acute care settings, different types of LTACHs and growth in Medicare spending on LTACHs. MedPAC is to submit a report to Congress with any recommendations by June 30, 2019. The report is to also include MedPAC’s assessment of whether the 25 Percent rule should continue to be applied.
25 Percent rule relief for freestanding LTACHs, HWHs and satellite facilities will be extended without interruption for cost reporting periods beginning on or after December 29, 2007 through December 28, 2016. Grandfathered HWHs will be permanently exempt from the 25 Percent rule. CMS must report to Congress by December 18, 2015 on whether the 25 Percent rule should continue to be applied.
The moratorium on new LTACH facilities and increases in LTACH beds will be renewed for the period from April 1, 2014 to September 30, 2017. Although the introductory language only refers to a moratorium extension for LTACH bed increases, the amendment to the Medicare, Medicaid, and SCHIP Extension Act (“MMSEA”) would extend both moratoriums. No exceptions will apply during this extension of the moratoriums. The original rule renewed the moratorium for the period beginning January 1, 2015; however, a provision within HR4302 accelerated the moratorium period beginning on April 1, 2014.
Not later than October 1, 2015, CMS will establish a new functional status quality measure for change in mobility of ventilator patients.

24


As part of the fiscal year 2015 or 2016 rulemaking, CMS is to study payment rates and regulations that apply to the special category of neoplastic disease LTACHs and may adjust such payment rates.
On August 4, 2014, CMS released its final rule for LTACH Medicare reimbursement for fiscal year 2015, which began on October 1, 2014 and ended on September 30, 2015. In the aggregate, payments for fiscal year 2015 increased by 1.1% over fiscal year 2014 rates. The 1.1% increase consisted of a 2.9% inflationary market basket update, offset by a 0.5% reduction for the productivity adjustment, and a 0.2% reduction to the market basket as defined by PPACA. LTACH payment rates were also be reduced by approximately 1.3% for the "one-time" budget neutrality adjustment factor under the last year of a three-year phase-in and increased by 0.2% for wage index budget neutrality adjustment.
On July 31, 2015, CMS issued a final rule to update fiscal year 2016 payment policies and rates under the IPPS and LTACH PPS, which affects discharges occurring in cost reporting periods beginning on or after October 1, 2015. CMS projects that LTACH PPS rates would decrease by 4.6%. This estimated decrease is primarily attributable to the statutory decrease in payment rates for site neutral LTACH PPS cases that do not meet the clinical criteria to qualify for higher LTACH rates in cost reporting years beginning on or after October 1, 2015. Cases that do qualify for higher LTACH PPS rates will see a payment rate increase of 1.7% (based on a market basket update of 2.4% adjusted by a multi-factor productivity adjustment of -0.5 percentage point and an additional adjustment of -0.2 percentage point in accordance with the Affordable Care Act). CMS also finalized its proposal to implement a transitional blended payment rate (50% site neutral rate and 50% LTACH PPS rates) for site neutral discharges occurring in fiscal years 2016 and 2017.
On October 1, 2015, CMS ICD-10 requirements for electronic billing transactions went into effect. In preparation, we have formally trained coding staff, invested in technology system upgrades, and provided compliance education for all ICD-10 changes.  At this early stage of implementation, we are not able to predict the financial impact that ICD-10 may have on our overall financial position due to possible delays in reimbursement, underpayment for services, or possible denials of payments from payors.
None of the above described estimated changes to Medicare payments for home health, hospice and LTACHs for 2016 include the deficit reduction sequester cuts to Medicare that began on April 1, 2013, which reduced Medicare payments by 2% for patients whose service dates ended on or after April 1, 2013.
RESULTS OF OPERATIONS
Three months ended September 30, 2015 compared to three months ended September 30, 2014
Consolidated financial statements
The following table summarizes our consolidated results of operations for the three months ended September 30, 2015 and 2014 (amounts in thousands, except percentages, which are percentages of consolidated net service revenue, unless indicated otherwise):
 
 
2015
 
 
2014
 
 
 
Increase
(Decrease)
 
Percentage
change of net service revenue
Net service revenue
$
204,122

 
 
 
 
$
187,713

 
 
 
 
 
$
16,409

 


Cost of service revenue
120,873

 
59.2
%
 
 
113,122

 
60.3
%
 
 
 
7,751

 
(1.1
)%
Provision for bad debts
4,809

 
2.4

 
 
3,974

 
2.1

 
 
 
835

 
0.3

General and administrative expenses
60,748

 
29.8

 
 
58,197

 
31.0

 
 
 
2,551

 
(1.2
)
Income tax expense
6,148

 
41.0

(1) 
 
3,924

 
38.9

(1)
 
 
2,224

 
2.1

Noncontrolling interest
2,265

 


 
 
1,679

 

 
 
 
586

 
 
Total non-operating income (expense)
(434
)
 


 
 
(643
)
 
 
 
 
 
(209
)
 
 
Net income attributable to LHC Group, Inc.’s common stockholders
$
8,845

 
 
 
 
$
6,174

 
 
 
 
 
$
2,671

 
 
 
(1)
Percentage of income tax from continuing operations attributable to LHC Group, Inc.’s common stockholders plus noncontrolling interest.

25


Net service revenue
The following table sets forth the growth or loss of each of our segment’s revenue and patient statistical data for the three months ended September 30, 2015 and the related change from the same period in 2014 (revenue amounts are in thousands):
 
 
Same
Store(1)
 
De
Novo(2)
 
Organic(3)
 
Organic
Growth
(Loss) %
 
Acquired(4)
 
Total
 
Total
Growth %
Home health services
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
150,832

 
$
860

 
$
151,692

 
5.6
 %
 
$
3,355

 
$
155,047

 
7.9
%
Revenue Medicare
$
116,208

 
$
590

 
$
116,798

 
4.8

 
$
2,972

 
$
119,770

 
7.5

New Admissions
34,760

 
196

 
34,956

 
2.9

 
816

 
35,772

 
5.3

New Medicare Admissions
23,327

 
130

 
23,457

 
2.1

 
657

 
24,114

 
5.0

Average Census
35,787

 
216

 
36,003

 
0.1

 
855

 
36,858

 
2.5

Average Medicare Census
26,418

 
144

 
26,562

 
(0.2
)
 
716

 
27,278

 
2.5

Home Health Episodes
46,909

 
248

 
47,157

 
1.1

 
906

 
48,063

 
3.1

Hospice services
 
 
 
 


 
 
 
 
 


 
 
Revenue
$
18,347

 
$
816

 
$
19,163

 
12.3
 %
 
$
42

 
$
19,205

 
12.5
%
Revenue Medicare
$
16,962

 
$
800

 
$
17,762

 
13.6

 
$
42

 
$
17,804

 
13.9

New Admissions
1,556

 
24

 
1,580

 
7.0

 
4

 
1,584

 
7.3

New Medicare Admissions
1,352

 
23

 
1,375

 
8.1

 
4

 
1,379

 
8.4

Average Census
1,464

 
61

 
1,525

 
9.8

 
3

 
1,528

 
10.0

Average Medicare Census
1,350

 
58

 
1,408

 
10.8

 
3

 
1,411

 
11.0

Patient days
134,767

 
5,519

 
140,286

 
9.7

 
306

 
140,592

 
10.0

Community-based services
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
$
10,377

 
$

 
$
10,377

 
15.6
 %
 
$
251

 
$
10,628

 
18.4
%
Billable hours
313,980

 

 
313,980

 
7.8

 
5,015

 
318,995

 
9.5

Facility-based services
 
 
 
 


 
 
 
 
 


 
 
LTACHs
 
 
 
 


 
 
 
 
 


 
 
Revenue
$
18,118

 
$

 
$
18,118

 
4.9
 %
 
$

 
$
18,118

 
4.9
%
Patient days
15,422

 

 
15,422

 
0.4

 

 
15,422

 
0.4


(1)
Same store — location that has been in service with us for greater than 12 months.
(2)
De Novo — internally developed location that has been in service with us for 12 months or less.
(3)
Organic — combination of same store and de novo.
(4)
Acquired — purchased location that has been in service with us for 12 months or less.
Total organic revenue for all four services segments for the three months ended September 30, 2015 increased as compared to the same period in 2014 due to an increase in patients on census, patient days, and billable hours and the successful execution of same store growth strategies.
Organic growth is primarily generated by population growth in areas covered by mature agencies and by increased market share in acquired and developing agencies. Historically, acquired agencies have the highest growth in admissions and average census in the first 24 months after acquisition, and have the highest contribution to organic growth, measured as a percentage of growth, in the second full year of operation after the acquisition.    
Cost of service revenue
The following table summarizes cost of service revenue (amounts in thousands, except percentages, which are percentages of the segment’s respective net service revenue):
 

26


 
Three Months Ended
September 30,
 
2015
 
2014
Home health services
 
 
 
 
 
 
 
Salaries, wages and benefits
$
81,165

 
52.4
%
 
$
75,975

 
52.9
%
Transportation
5,428

 
3.5

 
5,936

 
4.1

Supplies and services
3,420

 
2.2

 
3,394

 
2.4

Total
$
90,013

 
58.1
%
 
$
85,305

 
59.4
%
Hospice services
 
 
 
 
 
 
 
Salaries, wages and benefits
$
8,068

 
42.0
%
 
$
7,081

 
41.5
%
Transportation
830

 
4.3

 
813

 
4.8

Supplies and services
2,793

 
14.6